Trials (Dec 2021)
Unification of Treatments and Interventions for Tinnitus Patients (UNITI): a study protocol for a multi-center randomized clinical trial
- Stefan Schoisswohl,
- Berthold Langguth,
- Martin Schecklmann,
- Alberto Bernal-Robledano,
- Benjamin Boecking,
- Christopher R. Cederroth,
- Dimitra Chalanouli,
- Rilana Cima,
- Sam Denys,
- Juliane Dettling-Papargyris,
- Alba Escalera-Balsera,
- Juan Manuel Espinosa-Sanchez,
- Alvaro Gallego-Martinez,
- Efi Giannopoulou,
- Leyre Hidalgo-Lopez,
- Michael Hummel,
- Dimitris Kikidis,
- Michael Koller,
- Jose A. Lopez-Escamez,
- Steven C. Marcrum,
- Nikolaos Markatos,
- Juan Martin-Lagos,
- Maria Martinez-Martinez,
- Marta Martinez-Martinez,
- Maria Mata Ferron,
- Birgit Mazurek,
- Nicolas Mueller-Locatelli,
- Patrick Neff,
- Kevin Oppel,
- Patricia Perez-Carpena,
- Paula Robles-Bolivar,
- Matthias Rose,
- Tabea Schiele,
- Axel Schiller,
- Jorge Simoes,
- Sabine Stark,
- Susanne Staudinger,
- Alexandra Stege,
- Nicolas Verhaert,
- Winfried Schlee
Affiliations
- Stefan Schoisswohl
- Department of Psychiatry and Psychotherapy, University of Regensburg
- Berthold Langguth
- Department of Psychiatry and Psychotherapy, University of Regensburg
- Martin Schecklmann
- Department of Psychiatry and Psychotherapy, University of Regensburg
- Alberto Bernal-Robledano
- Department of Otolaryngology, Instituto de Investigacion Biosanitaria Ibs.GRANADA, Hospital Universitario Virgen de las Nieves
- Benjamin Boecking
- Tinnitus Center, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt Universität Berlin
- Christopher R. Cederroth
- Department of Physiology and Pharmacology, Karolinska Institutet
- Dimitra Chalanouli
- EXCELYA Hungary Kft.
- Rilana Cima
- Department of Health Psychology, Katholieke Universiteit Leuven
- Sam Denys
- Department of Neurosciences, Research group Experimental Oto-Rhino-Laryngology, University of Leuven
- Juliane Dettling-Papargyris
- Terzo-Institute for Applied Hearing Research, ISMA
- Alba Escalera-Balsera
- Otology & Neurotology Group CTS 495, Department of Genomic Medicine, GENYO, Center for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada
- Juan Manuel Espinosa-Sanchez
- Department of Otolaryngology, Instituto de Investigacion Biosanitaria Ibs.GRANADA, Hospital Universitario Virgen de las Nieves
- Alvaro Gallego-Martinez
- Otology & Neurotology Group CTS 495, Department of Genomic Medicine, GENYO, Center for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada
- Efi Giannopoulou
- EXCELYA Hungary Kft.
- Leyre Hidalgo-Lopez
- Department of Mental Health, Hospital Universitario Virgen de las Nieves
- Michael Hummel
- Central Biobank Charité, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt Universität Berlin
- Dimitris Kikidis
- Department of Otolaryngology, Head and Neck Surgery, National and Kapodistrian University of Athens, Hippocrateion General Hospital
- Michael Koller
- Center for Clinical Studies, University Hospital Regensburg
- Jose A. Lopez-Escamez
- Department of Otolaryngology, Instituto de Investigacion Biosanitaria Ibs.GRANADA, Hospital Universitario Virgen de las Nieves
- Steven C. Marcrum
- Department of Otolaryngology, University Hospital Regensburg
- Nikolaos Markatos
- Department of Otolaryngology, Head and Neck Surgery, National and Kapodistrian University of Athens, Hippocrateion General Hospital
- Juan Martin-Lagos
- Department of Otolaryngology, Instituto de Investigacion Biosanitaria ibs. GRANADA, Hospital Universitario Clinico San Cecilio
- Maria Martinez-Martinez
- Department of Otolaryngology, Instituto de Investigacion Biosanitaria Ibs.GRANADA, Hospital Universitario Virgen de las Nieves
- Marta Martinez-Martinez
- Department of Otolaryngology, Instituto de Investigacion Biosanitaria Ibs.GRANADA, Hospital Universitario Virgen de las Nieves
- Maria Mata Ferron
- Department of Otolaryngology, Instituto de Investigacion Biosanitaria Ibs.GRANADA, Hospital Universitario Virgen de las Nieves
- Birgit Mazurek
- Tinnitus Center, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt Universität Berlin
- Nicolas Mueller-Locatelli
- Department of Otolaryngology, Instituto de Investigacion Biosanitaria ibs. GRANADA, Hospital Universitario Clinico San Cecilio
- Patrick Neff
- Department of Psychiatry and Psychotherapy, University of Regensburg
- Kevin Oppel
- Terzo-Institute for Applied Hearing Research, ISMA
- Patricia Perez-Carpena
- Department of Otolaryngology, Instituto de Investigacion Biosanitaria Ibs.GRANADA, Hospital Universitario Virgen de las Nieves
- Paula Robles-Bolivar
- Otology & Neurotology Group CTS 495, Department of Genomic Medicine, GENYO, Center for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada
- Matthias Rose
- Department of Psychosomatic and Psychotherapy, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt Universität Berlin
- Tabea Schiele
- Tinnitus Center, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt Universität Berlin
- Axel Schiller
- Department of Psychiatry and Psychotherapy, University of Regensburg
- Jorge Simoes
- Department of Psychiatry and Psychotherapy, University of Regensburg
- Sabine Stark
- Tinnitus Center, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt Universität Berlin
- Susanne Staudinger
- Department of Psychiatry and Psychotherapy, University of Regensburg
- Alexandra Stege
- Central Biobank Charité, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt Universität Berlin
- Nicolas Verhaert
- Department of Neurosciences, Research group Experimental Oto-Rhino-Laryngology, University of Leuven
- Winfried Schlee
- Department of Psychiatry and Psychotherapy, University of Regensburg
- DOI
- https://doi.org/10.1186/s13063-021-05835-z
- Journal volume & issue
-
Vol. 22,
no. 1
pp. 1 – 16
Abstract
Abstract Background Tinnitus represents a relatively common condition in the global population accompanied by various comorbidities and severe burden in many cases. Nevertheless, there is currently no general treatment or cure, presumable due to the heterogeneity of tinnitus with its wide variety of etiologies and tinnitus phenotypes. Hence, most treatment studies merely demonstrated improvement in a subgroup of tinnitus patients. The majority of studies are characterized by small sample sizes, unstandardized treatments and assessments, or applications of interventions targeting only a single organ level. Combinatory treatment approaches, potentially targeting multiple systems as well as treatment personalization, might provide remedy and enhance treatment responses. The aim of the present study is to systematically examine established tinnitus therapies both alone and in combination in a large sample of tinnitus patients. Further, it wants to provide the basis for personalized treatment approaches by evaluating a specific decision support system developed as part of an EU-funded collaborative project (Unification of treatments and interventions for tinnitus patients; UNITI project). Methods/study design This is a multi-center parallel-arm randomized clinical trial conducted at five different clinical sites over the EU. The effect of four different tinnitus therapy approaches (sound therapy, structured counseling, hearing aids, cognitive behavioral therapy) applied over a time period of 12 weeks as a single or rather a combinatory treatment in a total number of 500 chronic tinnitus patients will be investigated. Assessments and interventions are harmonized over the involved clinical sites. The primary outcome measure focuses on the domain tinnitus distress assessed via the Tinnitus Handicap Inventory. Discussion Results and conclusions from the current study might not only provide an essential contribution to combinatory and personalized treatment approaches in tinnitus but could also provide more profound insights in the heterogeneity of tinnitus, representing an important step towards a cure for tinnitus. Trial registration ClinicalTrials.gov NCT04663828 . Registered on 11 December 2020.
Keywords